Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0001041885-25-000006·CORCEPT THERAPEUTICS INC
Schedule 13G ownership disclosure
Corcept Therapeutics Inc
Common Stock · CUSIP: 218352102
Event date: 2024-12-31
- Filing-level shares
- 8,173,721.00
- Percent of class
- 7.8%
- INGALLS & SNYDER LLC
Shares: 8,173,721.00 · Class: 7.8%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001041885-25-000006
- Form type
- SCHEDULE 13G/A
- Filer
- CORCEPT THERAPEUTICS INC
- CIK
- CIK 1088856
- Filed
- Feb 21, 2025
- Reporting period
- Dec 31, 2024
- Description
- Schedule 13G beneficial ownership